183 related articles for article (PubMed ID: 37788300)
1. Effective Treatment of SSTR2-Positive Small Cell Lung Cancer Using
Qin S; Yang Y; Zhang J; Yin Y; Liu W; Zhang H; Fan X; Yang M; Yu F
Mol Pharm; 2023 Nov; 20(11):5543-5553. PubMed ID: 37788300
[TBL] [Abstract][Full Text] [Related]
2. [Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].
Shen HC; Wang XW; Liu YG
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2498-503. PubMed ID: 19080633
[TBL] [Abstract][Full Text] [Related]
3. Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector.
Rogers BE; Zinn KR; Lin CY; Chaudhuri TR; Buchsbaum DJ
Cancer; 2002 Feb; 94(4 Suppl):1298-305. PubMed ID: 11877760
[TBL] [Abstract][Full Text] [Related]
4. RYZ101 (Ac-225 DOTATATE) Opportunity beyond Gastroenteropancreatic Neuroendocrine Tumors: Preclinical Efficacy in Small-Cell Lung Cancer.
Han G; Hwang E; Lin F; Clift R; Kim D; Guest M; Bischoff E; Moran S; Li G
Mol Cancer Ther; 2023 Dec; 22(12):1434-1443. PubMed ID: 37616528
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer.
Whalen KA; White BH; Quinn JM; Kriksciukaite K; Alargova R; Au Yeung TP; Bazinet P; Brockman A; DuPont MM; Oller H; Gifford J; Lemelin CA; Lim Soo P; Perino S; Moreau B; Sharma G; Shinde R; Sweryda-Krawiec B; Bilodeau MT; Wooster R
Mol Cancer Ther; 2019 Nov; 18(11):1926-1936. PubMed ID: 31649014
[TBL] [Abstract][Full Text] [Related]
6. Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside.
Lewin J; Cullinane C; Akhurst T; Waldeck K; Watkins DN; Rao A; Eu P; Mileshkin L; Hicks RJ
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):25-32. PubMed ID: 25125202
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging of naturally active melanin nanoparticles targeting somatostatin receptor subtype 2 in human small-cell lung cancer.
Xia L; Guo X; Liu T; Xu X; Jiang J; Wang F; Cheng Z; Zhu H; Yang Z
Nanoscale; 2019 Aug; 11(30):14400-14409. PubMed ID: 31334537
[TBL] [Abstract][Full Text] [Related]
8. Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro.
Liu Y; Xia H; Wang Y; Han W; Qin J; Gao W; Qu X; Wang X
Thorac Cancer; 2021 Nov; 12(22):3053-3061. PubMed ID: 34617400
[TBL] [Abstract][Full Text] [Related]
9. [99mTc-octreotide receptor scintigraphy in NCI-H446 small cell lung cancer nude mice model].
Li C; Zuo S; Wang X; Liu X; Wang G; Wu F
Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):1-7. PubMed ID: 25603866
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of astatine-211-labeled octreotide as a potential radiotherapeutic agent for NSCLC treatment.
Zhao B; Qin S; Chai L; Lu G; Yang Y; Cai H; Yuan X; Fan S; Huang Q; Yu F
Bioorg Med Chem; 2018 Mar; 26(5):1086-1091. PubMed ID: 29422331
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.
Lehman JM; Hoeksema MD; Staub J; Qian J; Harris B; Callison JC; Miao J; Shi C; Eisenberg R; Chen H; Chen SC; Massion PP
Int J Cancer; 2019 Mar; 144(5):1104-1114. PubMed ID: 30152518
[TBL] [Abstract][Full Text] [Related]
12. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
[TBL] [Abstract][Full Text] [Related]
13. Radiation induces up-regulation of somatostatin receptors 1, 2, and 5 in small cell lung cancer in vitro also at low absorbed doses.
Oddstig J; Bernhardt P; Nilsson O; Ahlman H; Forssell-Aronsson E
Cancer Biother Radiopharm; 2011 Dec; 26(6):759-65. PubMed ID: 22060188
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.
Fujita T; Yamaji Y; Sato M; Murao K; Takahara J
Life Sci; 1994; 55(23):1797-806. PubMed ID: 7968260
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.
Han L; Ravoori M; Wu G; Sakai R; Yan S; Singh S; Xu K; Roth JA; Ji L; Kundra V
Mol Imaging; 2013 Oct; 12(7):1-10. PubMed ID: 23962694
[TBL] [Abstract][Full Text] [Related]
17. Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.
He S; Zhou Z; Li L; Yang Q; Yang Y; Guan S; Zhang J; Zhu X; Jin Y; Huang Y
Drug Deliv; 2016; 23(1):285-96. PubMed ID: 24865288
[TBL] [Abstract][Full Text] [Related]
18. Identification of somatostatin receptors using labeled PEGylated octreotide, as an active internalization.
Abdellatif AAH
Drug Dev Ind Pharm; 2019 Oct; 45(10):1707-1715. PubMed ID: 31418304
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin Analog Therapy in Small Cell Lung Cancer.
Tartarone A; Lerose R; Aieta M
Semin Nucl Med; 2016 May; 46(3):239-42. PubMed ID: 27067504
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model.
Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Maecke HR; Forssell-Aronsson E
J Nucl Med; 2004 Sep; 45(9):1542-8. PubMed ID: 15347722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
